Factor 5 mutation profile in German patients with homozygous and heterozygous factor V deficiency

被引:27
作者
Delev, D. [1 ]
Pavlova, A. [1 ]
Heinz, S. [2 ]
Seifried, E. [2 ]
Oldenburg, J. [1 ]
机构
[1] Univ Clin Bonn, Inst Expt Hamatol & Transfus Med, D-53127 Bonn, Germany
[2] Univ Clin Frankfurt, Red Cross Blood Donor Serv, Inst Transfus Med & Immunohaematol, Frankfurt, Germany
关键词
factor V deficiency; mutation distribution; mutation profile; COAGULATION-FACTOR-V; ACTIVATED PROTEIN-C; MOLECULAR CHARACTERIZATION; MISSENSE MUTATION; CATALYZED ACTIVATION; BLOOD-COAGULATION; FACTOR-VIII; GENE; DOMAIN; ARG2074CYS;
D O I
10.1111/j.1365-2516.2009.02048.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coagulation factor V (FV) plays an important role in the blood coagulation cascade as part of the prothrombinase complex. FV deficiency is a rare autosomal recessive bleeding disorder with variable phenotypic expression. Thus, our study reports 39 patients with FV deficiency. In 36 cases, we were able to identify a causative mutation. Of these, 20 patients were heterozygous for the identified mutation, nine were homozygous, six were compound heterozygous and one proband was pseudohomozygous. In the remaining patients, no mutation was found. A total of 42 genetic alterations (of which 33 were uniquely different mutations), comprising 19 missense mutations, eight nonsense mutations, four small deletions and two splice site mutations, were identified by this study. Twenty-three of these were novel sequence variations not previously described in the literature. Interestingly, all changes found in exon 13 resulted in null alleles as either nonsense mutations or small deletions. The overall profile of these new mutations corresponds well with the data published in the F5 database. In those cases, where data were available, information on FV activity levels and/or bleeding history is given. Interestingly, some patients with mild FV deficiency (FV:C about 50% of normal) also exhibited bleeding episodes. Our data substantially contribute to the broadening and better understanding of the FV deficiency mutational spectrum. Identifying the molecular basis of mutations underlying this rare coagulation disorder will allow more insight into the mechanisms involved in the variable clinical phenotypes of patients with FV deficiency.
引用
收藏
页码:1143 / 1153
页数:11
相关论文
共 35 条
[1]   The crystal structure of activated protein C-inactivated bovine factor Va: Implications for cofactor function [J].
Adams, TE ;
Hockin, MF ;
Mann, KG ;
Everse, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (24) :8918-8923
[2]   Severe coagulation factor V deficiency caused by 2 novel frameshift mutations:: 2952delT in exon 13 and 5493insG in exon 16 of factor 5 gene [J].
Ajzner, A ;
Balogh, I ;
Szabó, T ;
Marosi, A ;
Haramura, G ;
Muszbek, L .
BLOOD, 2002, 99 (02) :702-705
[3]   Severe factor V deficiency: exon skipping in the factor V gene causing a partial deletion of the C1 domain [J].
Asselta, R ;
Montefusco, MC ;
Duga, S ;
Malcovati, M ;
Peyvandi, F ;
Mannucci, PM ;
Tenchini, ML .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (06) :1237-1244
[4]   Inherited defects of coagulation factor V: the hemorrhagic side [J].
Asselta, R ;
Tenchini, ML ;
Duga, S .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (01) :26-34
[5]   Factor V Arg2074Cys: A novel missense mutation in the C2 domain of factor V [J].
Bossone, A ;
D'Angelo, F ;
Santacroce, R ;
De Lucia, D ;
Margaglione, M .
THROMBOSIS AND HAEMOSTASIS, 2002, 87 (05) :923-924
[6]  
Castoldi E, 2001, HAEMATOLOGICA, V86, P629
[7]   Modelling and expression studies of two novel mutations causing factorV deficiency [J].
Delev, Daniel ;
Pavlova, Anna ;
Heinz, Stefan ;
Blaise, Mathias Costa ;
Chandra, Tamir ;
Poetsch, Bernd ;
Seifried, Erhard ;
Oldenburg, Johannes .
THROMBOSIS AND HAEMOSTASIS, 2008, 100 (05) :766-772
[8]   Arg2074Cys missense mutation in the C2 domain of factor V causing moderately severe factor V deficiency: molecular characterization by expression of the recombinant protein [J].
Duga, S ;
Montefusco, MC ;
Asselta, R ;
Malcovati, M ;
Peyvandi, F ;
Santagostino, E ;
Mannucci, PM ;
Tenchini, ML .
BLOOD, 2003, 101 (01) :173-177
[9]  
FOSTER WB, 1983, J BIOL CHEM, V258, P3970
[10]  
Guasch JF, 1997, THROMB HAEMOSTASIS, V77, P252